Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Medicament containing recombinant mistletoe lectins for the treatment of brain tumors

Medicament containing recombinant mistletoe lectins for the treatment of brain tumors

US Patent 10722553 · Granted Jul 28, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antiviral agent comprising recombinant mistletoe lectins2019
Drug containing recombinant mistletoe lectins for treating malignant melanoma2018
Antiviral agent comprising recombinant mistletoe lectins2017
Recombinant mistletoe lectin (rML)2001
Use of flavolignans as adjuvants in tumour therapy1998